Low-dose Spironolactone Combats Dyslipidemia and Hepatic Inflammation by Modulating PCSK9 in Rat Model of Polycystic Ovarian Syndrome

Kehinde S. Olaniyi,Stephanie E. Areloegbe,Emmanuel D. Areola,Isaiah W. Sabinari,Adedamola A. Fafure,Richard D. Agbana,Chukwubueze L. Atuma,Mohd Zahoor ul haq Shah,Isaac O. Ajadi,Lawrence A. Olatunji

Toxicology and applied pharmacology（2023）

引用 0|浏览11

暂无评分

关键词

Low dose spironolactone,Dyslipidemia,Liver,PCSK9,PCOS

AI 理解论文

溯源树

样例

生成溯源树，研究论文发展脉络

Chat Paper

正在生成论文摘要